Why the study?
The impact of long-term training on cardiovascular disease is not clear, and the association of circulating miRNAs with physical fitness and atherosclerosis markers in endurance athletes warrants evaluation.
Does long-term endurance training alter circulating miRNAs and correlate with physical fitness and markers of atherosclerosis in ultra-marathon runners?
Does long-term endurance training alter circulating miRNAs and correlate with physical fitness and markers of atherosclerosis in ultra-marathon runners?
Circulating miRNAs such as miR-125a-5p and miR-126 are altered in ultra-marathon runners and correlate with VO2max and carotid intima-media thickness, suggesting their potential as early biomarkers of atherosclerosis burden in athletes.
The impact of long-term training on cardiovascular disease (CVD) is not clear. Carotid intima–media thickness (CIMT) test is recommended as a useful measure to diagnose the early stages of atherosclerosis. MicroRNAs (miRNAs) are altered due to endurance exercise and can be promising biomarkers of pathophysiological changes. We aimed to evaluate the association of circulating miRNAs with physical fitness and markers of atherosclerosis in ultra-marathon runners. Ultra-marathon runners had 28-fold upregulation of miR-125a-5p expressions compared to control individuals (p = 0.002), whereas let-7e and miR-126 did not differ statistically between ultra-marathon runners and controls. In the ultra-marathon runners’ group, negative correlations were observed between VO2max/kg and relative expression of miR-125a-5p and miR-126 (r = −0.402, p = 0.028; r = −0.438, p = 0.032, respectively). Positive correlations were observed between CIMT and miR-125a-5p and miR-126 (r = 0.388, p = 0.050; r = 0.504, p = 0.023, respectively) in ultra-marathon runners. Individuals with the highest quartile of VO2max/kg had 23-fold lower miR-126 expression in comparison to subgroups with lower VO2max/kg (p = 0.017). Our results may indicate that both miRNAs may serve as a biomarker for early pathological changes leading to atherosclerosis burden in athletes. Furthermore, the association between miRNAs and traditional risk factors for CVD indicate a possible use of these molecules as early biomarkers of future cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Eyileten et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: